PRX302
Navigation Links
PRX302 in Medical Technology
Additional data to be published in an upcoming issue of
Anti-Cancer Drugs
VANCOUVER, March 20 /CNW/ - Protox(TM) Therapeutics Inc.
(TSX-V:PRX) today announced that two peer-reviewed publications
will feature Protox's PRX 302. The Journal of the National Cancer
Institute ("JNCI") has published th...
Protox Announces Positive Clinical Data from Prostate Cancer Study
...ostatic treatment. "The completion of the prx302 Phase 1 trial is encouraging from two perspective...adverse side effect profile at the highest dose of prx302 given to patients in this trial." "It is... safety, tolerability and therapeutic activity of prx302 in patients with localized recurrent prostate can...PRX302 in Biological Technology
New Report Just Published: World Prostate Cancer Therapeutics Market Report
...ere Gains Approval from Nice of UK for Use in Late-Stage Prostate Cancer II-62 Protox Gains Clearance from FDA to Conduct Phase I Trial of prx302 II-63 Aeterna Zentaris's Ozarelix Phase II Trial Shows Positive Results II-63 Biomira Announces Results of Stimuvax Phase 2 Clinical Study II-...PRX302 in other areas
PRX302. Brain Cancer. PRX321. Clinical Trials. Links. INVESTORS. News ... currently in clinical development include PRX302 for the treatment of benign ...
PRX302 is a pro-drug activated by prostate specific antigen (PSA), an enzyme ... PRX302 is injected into the prostate under sonographic guidance. ...
An Open-Label, Multi-Center, Phase IIa Trial of PRX302 Treatment of ...
Drug: PRX302 ... Previous treatment with PRX302. ... PRX302. Study placed in the following topic categories: Prostatic Diseases ...PRX302 is a pro-drug activated by prostate specific antigen (PSA), an enzyme ... PRX302 is injected into the prostate under sonographic guidance. ...
PSA-activated protoxin that kills prostate cancer: phase I clinical ...
Scientists have found a way of using a protein made by prostate cancer to target ... They engineered PRX302 to be activated by prostate-specific antigen (PSA) - a ...PipelineReview.com - Biotech News & Online Store - Protox Doses First ...
PipelineReview.com is the Biotech News Center and Online Store of La Merie Business Intelligence focused on Research ... believe that PRX302 has the potential ...PTXRF Protox initiates Phase II benign prostatic hyperplasia study
TradingMarkets News for PTXRF - Protox initiates Phase II benign prostatic ... The trial will also continue to assess safety and tolerability of PRX302. ...Other TagsNeisseriaOther Contentspapulepapilledemaparaffinparaffinparaffinsinusessinusesparanasalparanoiaparanoiaparanoia
NickelNeuropathologyNeurontinNetromycinNetilmicinNeothyllineNeopterinNeoralNembutalNelfinavirNeisseriaNavaneNebcinNasopharynx
(Date:12/15/2009)... of leptin associated with lower dementia risk, research finds ... levels of leptin, a hormone that regulates appetite, may ... in 10 or 15 years this may be one ... risk of Alzheimer,s disease," said senior study author Dr. ... University School of Medicine. "Or it may be one ...
(Date:12/15/2009)... 800,000 doses have lower strength than needed for protection, ... Almost 800,000 children,s doses of H1N1 swine flu vaccine ... they have lost some potency, federal health officials said ... Control and Prevention, the company,s routine testing of the ... years found that four batches had lower than required ...
(Date:12/15/2009)... tests promised but not delivered ,, WASHINGTON, ... on Congress to ensure that healthcare reform does ... required of insurance companies in 37 states. ,, ... segments of the population and individuals who are ... and men who have a family history of ...
(Date:12/15/2009)... Dec. 15 Knowledge ... the pharmaceutical and bio-tech research market with ... Over the past 11 years CMR has ... Consulting Network (PCN®), which now includes 70,000 ... both primary care and hard-to-reach specialties. ...
(Date:12/15/2009)... N.Y., Dec. 15 Team In Training ... charity sports training program, has reached ... support blood cancer research and patient services. ,, ... the pre-eminent charity endurance sports training program, preparing ... half marathon, triathlon, 100-mile century cycle ride or ...
Breaking Medicine News(10 mins):Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:Large Recall of Children's Swine Flu Vaccine 2Health News:Men's Health Network Calls on Congress to Complete President Obama's Promise on Health Care Reform 2Health News:Knowledge Networks Expands in Pharma Research With Acquisition of CMR 2Health News:$1 Billion - For Charity! 2Health News:$1 Billion - For Charity! 3(Date:12/15/2009)... GenWay Clinical Laboratory, San Diego, California, has been ... Pathologists (CAP), based on results of a recent ... was advised of this national recognition and congratulated ... GenWay Biotech Inc. GenWay Clinical Laboratory is one ... CAP Laboratory Accreditation Program, begun in the early ...
(Date:12/15/2009)... in German . , Leipzig: Species distribution ... future distribution of mammals. This is the finding of ... European mammals. The researchers analysed data on species distribution, ... phylogenetic information of the species. Judging by the large ... mammals seem to adapt fast to changing climatic conditions. ...
(Date:12/14/2009)... researchers are part of an international team that has ... to revise the history of North America,s woolly mammoths ... A Earth and Atmospheric Sciences professor Duane Froese and ... radiocarbon dating of bones and teeth. That analysis concluded ... North America (the ,megafauna,) disappeared about 13,000 years ago. ...
Breaking Biology News(10 mins):Species distribution models are of only limited value for predicting future mammal distributions 2Drug Offers Hope Against Tough to Treat Hypertension 56993 1Drug Offers Hope Against Tough to Treat Hypertension 56993 2Drug Offers Hope Against Tough to Treat Hypertension 56993 3In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 1In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 2In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 3In Vitro Study of Adamas Pharmaceuticals Triple Combination Antiviral Drug Therapy Shows Activity Against Drug Resistant Influenza Viruses 4981 4Opto electronic nose sniffs out toxic gases 9902 1Opto electronic nose sniffs out toxic gases 9902 2Opto electronic nose sniffs out toxic gases 9902 3| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |